Under the terms of the merger agreement, Sanofi will acquire DR-0201 through the acquisition of the Dren Bio affiliate ...
Sanofi (NASDAQ:SNY) has struck a major deal to acquire Dren Bios autoimmune disease treatment, DR-0201, reinforcing its ...
Madness: Watch DraftKings, FanDuel, Robinhood, and Grand Canyon. CoreWeave seeks shares ranging from $47 to $55 in IPO:report ...
And while it’s wreaking havoc on most stocks, some are bucking the trend, including: While markets sink, Regeneron ...
Jones Financial Companies Lllp raised its stake in Sanofi (NASDAQ:SNY – Free Report) by 55.0% during the 4th quarter, ...
The CDC has rescheduled a key advisory committee meeting on vaccine experts to April following a delay in February, a week ...
HighTower Advisors LLC increased its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 3.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC.
The U.S. Department of Agriculture (USDA) on Thursday announced a $100M investment to combat the transmission of the bird flu virus in poultry, adding to the Trump administration's previously ...
While markets sink, Regeneron Pharmaceuticals (NASDAQ:REGN) is up about 4%, or $30 on the day. Helping, the company and Sanofi (NASDAQ:SNY) just posted positive results from a pivotal ADEPT Phase ...